REMIFENTANIL vs RESLIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REMIFENTANIL vs RESLIZUMAB: Safety Overview
| Metric | REMIFENTANIL | RESLIZUMAB |
|---|---|---|
| Total FAERS Reports | 2,733 | 621 |
| Deaths Reported | 210 | 15 |
| Death Rate | 7.7% | 2.4% |
| Hospitalizations | 995 | 121 |
| Average Patient Age | 50.3 yrs | 55.9 yrs |
| % Female Patients | 48.2% | 63.2% |
| FDA Approval Date | Jan 16, 2018 | N/A |
| Manufacturer | Fresenius Kabi USA, LLC | Teva Respiratory, LLC |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |